At A Glance:

This sponsor was in a crucial race in the diabetes space as it began Phase III clinical trials for a new class of drug for type 2 diabetes. They were rolling into a crowded field of companies developing competitive compounds.

Download PDF
Indication:

Type 2 Diabetes


Enrollment time saved: 256 days
See the results